Boston Corporate Finance Advisors Directory

Top Corporate Finance Advisors in Boston, MA

TL;DR

Top corporate finance advisors in Boston, MA ranked by AI visibility. Bain Capital ($185B), TA Associates HQ'd here. Restructuring, valuations, and capital…

We evaluated 158 corporate finance advisors serving Boston and ranked the top 3 by TrustRank, our composite score of AI search visibility, verified client reviews, and expertise.

Boston's corporate finance market draws from its position as bain capital ($185b), ta associates hq'd here, creating consistent demand for valuations, capital raises, and restructurings.

Get Matched With a Top Boston Corporate Finance Advisor →
Updated Q1 2026
158 reviewed, 3 selected
50 prompts tracked
Boston Market Overview

Corporate Finance Advisors in Boston

Boston's corporate finance advisory market supports restructuring, capital raises, valuations, and strategic transactions across Massachusetts's business community. Bain Capital ($185B), TA Associates HQ'd here. The local market is shaped by Massachusetts's business environment and the active PE ecosystem, which includes Bain Capital, TA Associates, Advent International.

100+
Active corporate finance engagements
$250M+
Average restructuring case size
4–8wks
Typical valuation turnaround
63%
Engagements with PE involvement

Corporate finance dealmakers network through ACG Boston and CFA Society Boston, 6,000+ members; NE's largest (est. 1946). Boston's position in Massachusetts makes it a hub for bain capital ($185b), ta associates hq'd here.

ACG BostonCFA Society Boston, 6,000+ members; NE's largest (est. 1946)NAIFA Massachusetts

How TrustRank Works

Our independent scoring system for corporate finance advisors in Boston

TrustRank is not a paid placement. We independently evaluated 158 corporate finance advisors serving Boston across three measurable dimensions. No firm can pay to appear or improve its rank.

TrustRank weights AI search visibility at 55%, review quality at 25%, and content authority at 20%. The ranking methodology sets out each component, the data sources, and how rankings are updated. In Boston, 158 corporate finance advisors were evaluated and the top 3 are listed below, each scored on the same three components. Firms are ranked only against other firms serving Boston in this category, so a score here is not comparable with the same firm in another market. Each profile below shows the inputs behind its own scores, and rankings are re-run when new reviews or AI visibility results arrive, so the order can change between updates.

Top 3 Corporate Finance Advisors in Boston, MA

1
Alvarez & Marsal
Serves Boston, MA
96%
AI Visibility
★★★★★4.8
Retainer Est. 1983 Min: $50M revenue

Premier turnaround and performance improvement firm with a major Boston practice, specializing in financial restructuring, operational transformation, and dispute advisory.

turnaround advisor Bostonrestructuring firm BostonAlvarez Marsal Boston
RestructuringPerformance ImprovementDispute Advisory
2
Houlihan Lokey Corporate Finance
Serves Boston, MA
89%
AI Visibility
★★★★★5
Project Fee Est. 1972 Min: $50M revenue

Corporate finance advisory arm of Houlihan Lokey with Boston advisors specializing in fairness opinions, valuations, and restructuring advisory for complex transactions.

Houlihan Lokey Bostonfairness opinion Bostonbusiness valuation Boston
Fairness OpinionsValuationsRestructuring
3
Stout Risius Ross
Serves Boston, MA
81%
AI Visibility
★★★★★4
Project Fee Est. 1998 Min: $5M revenue

Investment bank and advisory firm with Boston expertise in business valuation, transaction opinions, and dispute advisory for privately held businesses and legal proceedings.

Stout Risius Bostonbusiness valuation firm Bostonvaluation advisory Boston
Business ValuationTransaction OpinionsDispute Advisory

Corporate Finance Market Overview, Boston, MA

Boston's corporate finance advisory market is driven by its extraordinary life sciences ecosystem. CFOs and financial advisors here must navigate FDA milestone accounting, clinical trial expense modeling, and the unique cash-burn dynamics of pre-revenue biotech companies. The public markets sophistication of Boston biotech CFOs is among the highest in the US.

Market Indicator Data Point
Life Sciences CFO HiresAnnual: 180+
VC Investment (2023)$14.8B
Biotech IPOs (2023)22
Active PE-Backed Firms600+

Regulatory & Licensing Environment

Massachusetts imposes a 9% flat income tax rate and a 4% surtax on income above $1M (effective 2023). Corporate excise tax applies to MA-domiciled companies at $2.60 per $1,000 of taxable value. Life sciences companies may qualify for MA Life Sciences Tax Incentive Program credits. SEC reporting requirements apply to public biotech companies under Reg S-K and S-X.

Corporate Finance Fees in Boston, MA

Fee Type Typical Range
Life Sciences CFO (full-time)$250,000–$450,000 base + equity
Fractional CFO (biotech)$15,000–$30,000/month
IPO Advisory$100,000–$300,000 retainer
SPAC Advisory$150,000–$400,000

Boston biotech CFOs command the highest compensation of any US corporate finance market due to the combination of life sciences expertise, public company experience, and FDA regulatory knowledge. Equity packages for pre-IPO biotech CFOs typically include 0.5–1.5% of fully diluted shares.

How to Choose a Corporate Finance in Boston, MA

  • FDA milestone accounting: Biotech companies capitalize or expense clinical development costs based on GAAP ASC 730. Your CFO must understand when costs are expensed vs. capitalized, how milestone payments are treated, and how to present clinical spend to investors.
  • Public biotech experience: Boston biotech companies frequently go public via IPO or SPAC. CFOs with prior public company experience (SEC filings, SOX compliance, investor relations) are essential, naive private company CFOs create material SEC compliance risk.
  • Massachusetts surtax planning: The 4% MA surtax on income above $1M significantly affects executive compensation design and equity distribution. Your CFO should model after-tax executive economics including surtax exposure in compensation committee decisions.

Frequently Asked Questions

Common questions about choosing corporate finance in Boston, MA.

What makes a biotech CFO different from a regular tech CFO?+−
Biotech CFOs must understand FDA milestone accounting, clinical trial accrual methodologies, grant revenue recognition (NIH/BARDA grants), and non-dilutive financing structures. They also need capital markets experience for follow-on equity offerings, which biotech companies do frequently.
How is cash burn modeled for a pre-revenue Boston biotech?+−
Biotech burn rate models project: clinical trial enrollment pace (which drives CRO costs), headcount growth, facility costs, and key milestone dates. A sophisticated CFO models multiple scenarios (fast enrollment, slow enrollment) tied to specific FDA interaction timelines.
What is the Massachusetts Millionaire's Tax and how does it affect CFO compensation?+−
Massachusetts imposes an additional 4% income tax on annual income above $1M (effective 2023). This affects executive compensation design, companies may use deferred compensation, restricted equity grants, or performance-based structures to smooth income below the $1M threshold.
Do Boston biotech companies typically go public via IPO or SPAC?+−
Traditional IPOs remain the preferred path for Boston biotech with strong clinical data. SPACs surged from 2020–2021 but declined sharply by 2022–2023 due to poor post-merger performance. Most biotech boards now favor IPO or M&A exit over SPAC for clinical-stage companies.
What corporate finance work is specific to Boston's life sciences market?+−
NIH and BARDA grant accounting, clinical CRO contract management, orphan drug designation implications, milestone payment contingency accounting, and FDA user fee budgeting (PDUFA fees) are Boston-specific corporate finance competencies rarely needed in other markets.
When should I hire a corporate finance advisor in Boston?+−
Hire a corporate finance advisor for financial restructuring, capital raises, fairness opinions, business valuations, or strategic transactions. Look for professionals with relevant industry experience, and verify their credentials through FINRA or your state bar for legal advisors.
How is this Boston corporate finance advisor ranking calculated?+−
ProCloser.ai's TrustRank score combines AI Visibility Score (55%), Review Score (25%), and Content Authority (20%). Rankings are updated quarterly and cannot be influenced by payment.

Reviewed by:  |  Last Updated: April 2026  |  Sources: SEC IAPD, FINRA BrokerCheck, state regulatory filings, ProCloser.ai primary research.

Is Your Firm Not Listed?

If you're a corporate finance advisors serving Boston and want to improve your AI search visibility, ProCloser.ai can help you appear when prospects ask ChatGPT, Perplexity, and Google AI Overviews for recommendations.